Proactively Building a Robust Safety System Pharmacovigilance and Risk Management Strategies Summit

Transcription

1 3 rd Annual Conference Proactively Building a Robust Safety System Pharmacovigilance and Risk Management Strategies Summit May 25-26, Hyatt at The Bellevue, Philadelphia.

2 Conference In Numbers 20+ Speakers 2 Days 10 Hours of Networking 17 Hour Program 7 Pro-active Pharmacovigilance case studies 6 hot topics for Lunch n Learn discussions Top Speakers Debra Feldman Vice President, Global Pharmacovigilance and Epidemiology Bristol-Myers Squibb Alexander Kluczka Global Pharmacovigilance, Head TA Oncology - ICSR Processing Bayer Healthcare Gerrit-Jan Nijveldt Senior Director, Global Labeling Sanofi Paul Beninger Vice President, Global Patient Safety Genzyme Anthony Vuolo Director, Pharmacovigilance and Risk Management Business Insights Shire Lisa Weiss Director, Epidemiology, Worldwide Safety Strategy Pfizer Top Presentations New directions in benefit-risk assessments and risk management plans by Bristol-Myers Squibb Signal detection, signal management and labeling compliance excellence by Sanofi Exploring new data sources and comparing them to the existing ones by Pfizer Individual case safety report process optimization and automation by Bayer Inspection readiness and practical implications of safety governance by Halloran, Indivior, Shire and Fresenius Medical Care Game theory in implementing drug safety solutions by Genzyme

3 Highlights Executive visions keynote: Pharmacovigilance of orphan drug companies vs. big pharma Interactive workshop: Signal detection and labeling compliance Featured discussions: PhV outsourcing and smart panel on inspection readiness Benchmarking roundtables and knowledge sharing panels Lunch n Learn sessions on both summit days 7 Pro-active Pharmacovigilance case studies Our Thank You Victoria Lambert Senior Production Specialist Fleming. Dear Industry Experts, The 3 rd edition of our Pharmacovigilance & Risk Management Strategies Summit series was a unique event and a great success. Expert speakers and senior-level industry professionals shared their first-hand experience and solutions for overcoming the latest challenges in the field. An open, problem-solving atmosphere and an interactivity-driven program helped the delegates to learn something new and make useful connections for the future. Fleming. s event format for Pharmacovigilance conferences in North America have maintained a strong footprint as compared to the competitors and thanks to the speed of innovation in safety governance, signal detection, risk minimization, reporting quality and patient engagement, we would like to build on this year s experience and come up with something even more exciting in The 4 th Annual Pharmacovigilance & Risk Management Strategies Summit, scheduled for Washington D.C., June 6-7, 2017 shall unveil features and power-packed sessions designed as per participant feedback. We look forward to welcoming you again. Kind regards, Victoria

4 Testimonials Job Title Distribution I was extremely impressed with how the conference was coordinated and the Fleming personnel were outstanding. This conference was coordinated perfectly interesting and enjoyable. Amy LaClair, UBC, Associate Project Director Topics discussed were relevant to my role as a Pharmacovigilance Scientist. Panel discussions, breakout roundtable sessions and Lunch n Learn networking sessions were of great interest! Rita Petroro, BMS, Senior Pharmacovigilance Scientist The real-life experience and lessons learned by fellow PV professionals are very useful to the efficient performance of my duties and responsibilities. Great summit! Buenaflor Nicolas, Cytokinetics, Director, Drug Safety Extremely interesting event. Superb content, great delivery, very comfortable venue. Outstanding opportunity to network and exchange best business practices! JP Clement, JP Clement Pharmacovigilance, Pharmacovigilance Expert 25% 42% 33% CxOs, VPs Directors, Heads Senior Management Geographical Distribution How Did the Delegates Benefit? 94% 82% 88% of the attendees would recommend the event to their colleagues of the attendees intend to attend next year of the attendees appreciated the many networking opportunities 95% North America 5% Europe

5 Company List AbbVie Adare Pharmaceuticals Inc. Alexion Allergan Anacor Pharmaceuticals ArisGlobal LLC Ashfield Pharmacovigilance Baxalta Bayer Booz Allen Hamilton Bristol-Myers Squibb C3i Healthcare Connections CSL Behring Cytokinetics Eli Lilly and Company Epidemico Fresenius Medical Care Genzyme Halloran Consulting Group, Inc. ICON PLC Idera Pharmaceuticals Infinity Pharmaceuticals JP Clement Pharmacovigilance Mesoblast Pfizer PrimeVigilance Procter & Gamble Real Staffing Regeneron Pharmacueticals Inc Rutgers University RxLogix Sanofi Sciformix Shire Teva Pharmacueticals Trevena, Inc UBC Vigilare Partners Ashfield Pharmacovigilance

6 The Next Annual 4 th Annual Pharmacovigilance and Risk Management Strategies Summit June 6-7, Washington D.C. For sponsorship opportunities: Isaac McNulty Director Fleming. Chicago, U.S.A. T: F: E: isaac.mcnulty@fleming.events For media partnership opportunities: Martina Hrabinska Marketing Manager Fleming. Bratislava, Slovak Republic T: F: E: martina.hrabinska@fleming.events About Fleming. Fleming. connects great people, useful know how and valuable opportunities. With 12 years in the business and 300+ events organized annually, Fleming. has grown to offer a portfolio of Conferences, Trainings, Exhibitions, Blended Learning and Online Conferences. Present on five continents, Fleming. has partnerships to always stay one step ahead. More than 50,000 satisfied companies participating at our events every year prove that Fleming. is the right partner.